Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex.

Cardiomyopathy (CM) is a primary degenerative disease of myocardium and is traditionally categorized into hypertrophic and dilated CMs (HCM and DCM) according to its gross appearance. Cardiomyopathic hamster (CM hamster), a representative model of human hereditary CM, has HCM and DCM inbred sublines, both of which descend from the same ancestor. Herein we show that both HCM and DCM hamsters share a common defect in a gene for delta-sarcoglycan (delta-SG), the functional role of which is yet to be characterized. A breakpoint causing genomic deletion was found to be located at 6.1 kb 5' upstream of the second exon of delta-SG gene, and its 5' upstream region of more than 27.4 kb, including the authentic first exon of delta-SG gene, was deleted. This deletion included the major transcription initiation site, resulting in a deficiency of delta-SG transcripts with the consequent loss of delta-SG protein in all the CM hamsters, despite the fact that the protein coding region of delta-SG starting from the second exon was conserved in all the CM hamsters. We elucidated the molecular interaction of dystrophin-associated glycoproteins including delta-SG, by using an in vitro pull-down study and ligand overlay assay, which indicates the functional role of delta-SG in stabilizing sarcolemma. The present study not only identifies CM hamster as a valuable animal model for studying the function of delta-SG in vivo but also provides a genetic target for diagnosis and treatment of human CM.

[1]  J. Perloff,et al.  The Cardiomyopathy of Progressive Muscular Dystrophy , 1966, Circulation.

[2]  K. Campbell,et al.  Identification and Characterization of the Dystrophin Anchoring Site on β-Dystroglycan (*) , 1995, The Journal of Biological Chemistry.

[3]  G. Viglietto,et al.  Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. , 1996, Human molecular genetics.

[4]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[5]  J. McPherson,et al.  Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy* , 1996, The Journal of Biological Chemistry.

[6]  J. Beckmann,et al.  Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.

[7]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[8]  G. Heijne.  A new method for predicting signal sequence cleavage sites. , 1986 .

[9]  Robert Tjian,et al.  Promoter-specific activation of RNA polymerase II transcription by Sp1 , 1986 .

[10]  S. Solomon,et al.  A molecular basis for familial hypertrophic cardiomyopathy: An α β cardiac myosin heavy chain hybrid gene , 1990, Cell.

[11]  M. Passos-Bueno,et al.  Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.

[12]  J. Beckmann,et al.  β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12 , 1995, Nature Genetics.

[13]  K. Campbell,et al.  Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. , 1996, The New England journal of medicine.

[14]  G. Jasmin,et al.  CARDIOMYOPATHY OF HAMSTER DYSTROPHY * , 1979, Annals of the New York Academy of Sciences.

[15]  M. Shigekawa,et al.  Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart , 1993, FEBS letters.

[16]  J. Ervasti,et al.  Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. , 1993, Journal of Biological Chemistry.

[17]  U. Francke,et al.  Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. , 1993, Human molecular genetics.

[18]  M. Yanagisawa,et al.  Cloning and functional expression of human cDNA for the ETB endothelin receptor. , 1991, Biochemical and biophysical research communications.

[19]  T. Toyo-Oka,et al.  Noninvasive Assessment of Cardiomyopathy Development With Simultaneous Measurement of Topical 1H‐ and 31P‐Magnetic Resonance Spectroscopy , 1992, Circulation.

[20]  K. Nakao,et al.  Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists. , 1993, The Journal of biological chemistry.

[21]  S. C. Hubbard,et al.  Synthesis and processing of asparagine-linked oligosaccharides. , 1981, Annual review of biochemistry.

[22]  L. Kunkel,et al.  The structural and functional diversity of dystrophin , 1993, Nature Genetics.

[23]  L. Kunkel,et al.  Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.

[24]  W. Giles,et al.  Calcitonin gene-related peptide regulates calcium current in heart muscle , 1989, Nature.